ArticleJournal of dental sciences2026
Biofunctionalized 3D-printed gelatin-alginate scaffolds with arginine-glycine-aspartic acid (RGD) peptides for enhanced
Article in Journal of dental sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Development of Acellular Matrix-Based Bioprinted Scaffold for Inferior Alveolar Nerve Regeneration.ACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Alveolar bone defects are difficult to treat due to ongoing resorption and limitations of conventional grafts. Tissue engineering strategies, particularly 3D hydrogel-based scaffolds, offer promising alternatives by mimicking the extracellular matrix and supporting cell-driven regeneration. This study aimed to incorporating arginine-glycine-aspartic acid (RGD) peptides into 3D-printed gelatin-alginate hydrogels to enhances their bioactivity and osteogenic potential for effective alveolar bone repair. Materials and methods: The physical characterization of RGD peptides-grafted 3D-printed gelatin-alginate scaffolds was conducted using morphological observation, elemental composition analysis, Fourier-transform infrared spectroscopy (FTIR), and assessments of swelling and degradation behavior. Biological performance was examined Results: RGD peptides-grafted 3D-printed gelatin-alginate scaffolds exhibited a porous architecture. Elemental and FTIR analyses confirmed successful peptide incorporation through elevated nitrogen and oxygen content, along with amide and C-H stretching bands. The scaffolds showed stable swelling, reduced degradation, and significantly enhanced MG-63 cell adhesion, proliferation, ALP activity, and mineralization, particularly in the 0.5 mg/mL RGD peptides-grafted group. Conclusion: RGD peptides modification significantly enhances the structural and biological performance of 3D gelatin-alginate scaffolds, reinforcing their potential as effective materials for alveolar bone regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.